BAX — Put-Selling Research

by ThetaLoop Research
← Back to search
Last close: 2026-04-02
Baxter International Inc.
Healthcare · $16.68
3.6
/10
Weak
How this score works →
Regime
Bearish
vs SMA200
SMA200 Distance
-24%
Below trend
Volatility
Normal
Average premiums
Momentum
Accelerating
Price direction
About Baxter International Inc.
Makes IV solutions, infusion pumps, surgical products, and renal therapies after spinning off its kidney care unit (Vantive) in 2024. Pays a modest dividend. Post-spinoff, BAX trades cheaply with lower volatility than most healthcare names — a reasonable defensive put-selling pick.
Medical Products & Therapies
Market Cap
$8.6B
Dividend
216.00%
Beta
0.62
52-Week Range Current: $16.68
$15.73 $32.68
Earnings
2026-04-30
25 days away
📊 View Full Research Track Record (All Wins AND Losses)
These free tools show market conditions and individual scores.
Our daily research goes deeper — covering option-specific data points, strike analysis, and risk metrics delivered via Telegram.
EXPLORE OUR RESEARCH — 14 DAYS FREE